“Selecting quality genetics is a fundamental aspect of producing premium cannabis, so we are delighted to be joining forces with such a distinguished and globally recognized breeder as Serious Seeds,” said Randall MacLeod, CEO of Canary Rx Inc. “This is just one strategic partnership for Canary as we position ourselves to become Canada’s preferred producer of premium cannabis products.”
Canary Rx Inc. (“Canary”) is a final-stage Licensed Producer (“LP”) applicant, under the ACMPR. Situated in Ontario’s Garden, Norfolk County, Canary lies nestled among-st the shores of Lake Erie in a vibrant, agricultural community. Our 44,000 sq. ft. facility is engineered to meet strict quality control standards and will be equipped with the latest environmental control technology. Once complete, it’s expected to produce 3,600kg of cannabis per year. Canary is currently positioning itself as a premium cannabis lifestyle brand, with a focus on producing pure, curated, cannabis products. Our modern, minimalist branding will grow with the company, and evolving social and political conditions, situating us to appeal to medical as well as to recreational markets.
The groundbreaking partnership will see Serious Seeds breeding their original strains at Canary’s 44,000 sq. ft. facility in Norfolk County, Ontario, as well as developing new genetics for the emerging recreational market. Canary will also have exclusive access to Serious Seeds’ current catalog of strains, providing Canadian growers with legal access to world-class genetics.
About Canary RX Inc.
NORFOLK COUNTY, ON, Dec. 11, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Target Group Inc. (OTCQB: CBDY) today announced that its wholly owned subsidiary, Canary Rx Inc. (“Canary”) has entered into an exclusive global partnership agreement with Serious Seeds B.V. in all legal cannabis markets (“Serious Seeds”). Serious Seeds is a world renowned and highly acclaimed Dutch seed bank known for breeding premium cannabis strains, including AK-47, Chronic, Bubblegum, Kali Mist and White Russian.
About Target Group Inc. (OTCQB: CBDY)
About Serious Seeds
Target Group, Inc. is a diversified and vertically integrated progressive company with focus on both national and international presence. The Company operates a wholly-owned late stage Canadian licensed producer regulated under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR): Canary RX, which operates a 44,000 square foot facility located in Norfolk County, Ontario. The Company has begun structuring multiple international production and distribution platforms and intends to continue rapidly expanding its global footprint as it focuses on building an iconic brand portfolio whose focus aims at developing cutting edge Intellectual Property among the medical and recreational cannabis markets. Target Group is committed to building industry-leading companies that transform the perception of cannabis and responsibly elevate the overall consumer experience.
Serious Seeds has earned its reputation over decades, despite significant legal and regulatory restraints. Such passion, dedication and expertise is a relatively untapped resource, often overlooked by the deluge of industry newcomers. Canary will continue to seek out partnerships with veterans of the cannabis community that deserve recognition in the newly emerging legal market.
NORFOLK COUNTY, ON, Dec. 11, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Target Group Inc. (OTCQB: CBDY) today announced that its wholly owned…